Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 11:34 am Sale | 2024-09-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BRANDES INVESTMENT PARTNERS LP | 0 0.000% | -745,079 (Position Closed) | Filing History |
| 2024-11-14 10:25 am Sale | 2024-09-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -775,525 (Position Closed) | Filing History |
| 2024-11-12 1:24 pm Purchase | 2024-09-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | CITIGROUP INC C | 1,000,036 7.700% | 1,000,036 (New Position) | Filing History |
| 2024-11-05 4:32 pm Purchase | 2024-10-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Nantahala Capital Management, LLC | 3,945,209 30.400% | 1,983,139 (+101.07%) | Filing History |
| 2024-10-31 1:36 pm Purchase | 2024-10-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Union Square Park Capital Management LLC | 1,321,385 10.170% | 129,895 (+10.90%) | Filing History |
| 2024-10-09 4:05 pm Sale | 2024-10-02 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Orin Hirschman | 0 0.000% | -1,061,509 (Position Closed) | Filing History |
| 2024-10-08 12:42 pm Purchase | 2024-10-03 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Union Square Park Capital Management LLC | 1,191,490 9.170% | 1,191,490 (New Position) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BlackRock Inc. BLK | 351,570 2.700% | -632,505 (-64.27%) | Filing History |
| 2024-07-03 2:02 pm Purchase | 2024-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Nantahala Capital Management, LLC | 1,962,070 15.100% | 1,962,070 (New Position) | Filing History |
| 2024-03-18 8:37 pm Sale | 2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Tarriff Scott | 2,470,570 17.600% | -62,887 (-2.48%) | Filing History |
| 2024-02-14 5:09 pm Purchase | 2024-02-12 | 13D | Eagle Pharmaceuticals, Inc. EGRX | Graves Michael | 238,660 1.800% | 238,660 (New Position) | Filing History |
| 2024-02-13 5:04 pm Sale | 2023-12-29 | 13G | Eagle Pharmaceuticals, Inc. EGRX | The Vanguard Group | 638,124 4.910% | -125,683 (-16.45%) | Filing History |
| 2024-02-13 3:53 pm Sale | 2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 775,525 6.000% | -454,347 (-36.94%) | Filing History |
| 2024-02-12 1:38 pm Purchase | 2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BRANDES INVESTMENT PARTNERS LP | 745,079 5.740% | 745,079 (New Position) | Filing History |
| 2024-02-07 09:15 am Purchase | 2024-01-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Orin Hirschman | 1,061,509 8.200% | 1,061,509 (New Position) | Filing History |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BlackRock Inc. BLK | 984,075 7.600% | -25,015 (-2.48%) | Filing History |
| 2024-01-22 2:04 pm Sale | 2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | STATE STREET CORP STT | 222,594 1.710% | -729,432 (-76.62%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BlackRock Inc. BLK | 1,009,090 7.700% | -863,811 (-46.12%) | Filing History |
| 2023-02-14 4:34 pm Purchase | 2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Tarriff Scott | 2,533,457 18.060% | 113,483 (+4.69%) | Filing History |
| 2023-02-13 09:26 am Sale | 2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 1,229,872 9.400% | -298,280 (-19.52%) | Filing History |